Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
Articles by Ana Barros
Recent Posts
- Cerebrovascular, cardiovascular disease risk seen higher in SSc
- FDA grants orphan drug status to BLR-200 for scleroderma
- 2 blood proteins may help detect lung issues in scleroderma patients
- Resilience may curb negative effects of feeling socially isolated: Study
- CABA-201 gets FDA orphan drug status as scleroderma treatment
- How scleroderma has changed my face, despite my best efforts
- T-helper cells may affect lung disease severity in SSc: StudyÂ
- Joint inflammation, health-related quality of life linked in SSc: Study
- Cognitive difficulties, malnutrition can be common with scleroderma
- Frequency of muscle disease in SSc shows need for biomarkers: Study